Study Assesses Neuropathic Pain Risk for Breast Cancer Patients

	Tweet

Breast cancer patients treated with the chemotherapy drug Taxol (paclitaxel) are more likely to develop chronic neuropathic pain, according to research published in The Journal of Pain, the peer review publication of the American Pain Society.

Researchers from the University of Texas MD Anderson Cancer Center conducted a survey of breast cancer patients who participated in clinical trials of Taxol from 1994 to 2001. There were 240 respondents. The purpose of the study was to determine the association between chemotherapy-induced peripheral neuropathy (CIPN) and neuropathic pain in breast cancer patients treated with Taxol. The authors noted that few studies have examined the extent to which breast cancer survivors who experience CIPN during chemotherapy go on to develop chronic neuropathic pain.

Though survival rates for breast cancer have increased significantly, chemotherapy agents that make survival possible can cause structural damage to peripheral nerves, causing chronic pain from the resulting dysfunction in the nervous system. Dose-limiting toxicity for many chemotherapeutic agents is peripheral neuropathy.

The study results showed that breast-cancer patients who had experienced CIPN during their treatment with Taxol were three times more likely to eventually be diagnosed with chronic neuropathic pain. Taxol-treated patients, therefore, should be regularly monitored for neuropathic pain beyond treatment.

The authors pointed out that the same cellular mechanism altered by Taxol to kill tumors can be toxic to normal tissue. They explained further that patients at MD Anderson given weekly doses of Taxol are monitored closely for symptoms of worsening CIPN. In some cases, physicians and patients should review the risks and benefits for continuing Taxol if worsening neuropathy is likely.

Source:  American Pain Society

RELATED STORIES:
Even Tiny Breast Tumors Can be Aggressive and May Require Maximum Therapy   Hair straightening chemicals not linked to breast cancer risk in African-Americans   Not all breast cancers’ risk are increased by Hormone Replacement Therapy   Breast cancer risk lower in migraine sufferers   Women with Certain Type of Ovarian Cancer and BRCA Gene Mutation Have Improved Survival at 5 Years   Scientists unravel breast cancer risk gene mystery   Calcium pills no help against breast cancer: study   Drop in breast cancer incidence linked to hormone use, not mammograms   10,000-plus in US die for lack of cancer screens: CDC   Device for testing breath for the presence of metabolites associated with breast cancer   Simple fingertip test may identify breast cancer patients at risk for carpal tunnel syndrome   Breast cancer Estimating risk   Daily stress may stop breast cancer   New tool predicts women’s outcome in breast cancer   Study shows long-term benefits of breast screening   Scientists find new drug target in breast cancer   Early-Stage Breast Cancer Patients Who Receive Neoadjuvant Therapy   Understanding individual genetic variation can help predict chemotherapy side effects   Smoking not linked to more advanced breast cancer   Breast cancer deaths decline more slowly for some   Breast MRI Detects Additional “Unsuspected” Cancers Not Seen on Mammography or Ultrasoun   The most aggressive forms of breast cancer elude the cellular control mechanisms in order to expand

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]